Bell palsy was significantly more common after SARS-CoV-2 infection (n=2822072) than after SARS-CoV-2 vaccinations (n=37912410) (relative risk, 3.23; 95% CI, 1.57-6.62; I2=95%). MJ, Hutchison
RF, Basura
B, Roel
This article is protected by copyright. T, Yang
et al. Importance Little is known about the factors associated with COVID-19 vaccine adverse effects in a real-world population.. , Pothiawala
Quality Assessment of the Case Controls Using the Newcastle-Ottawa Scale (NOS) Modified for Case-Control Studies, eTable 6. , Viechtbauer
It was also not possible to control for some of the known BP risk factors, such as diabetes, obesity, hypertension, upper respiratory tract disease, or pregnancy, because most studies have not provided sufficient data on these risk factors.102 In addition, the recorded BP cases following vaccination might have been prone to a reporting bias from heightened awareness because researchers have constantly sought to record adverse events during the COVID-19 pandemic. , Assiri
V, Marttila
N. Learn more about the GBS and a possible vaccine link. Ann Neurol. R, Hukkanen
All Rights Reserved, Challenges in Clinical Electrocardiography, Clinical Implications of Basic Neuroscience, Health Care Economics, Insurance, Payment, Scientific Discovery and the Future of Medicine, Published online April 27, 2023. doi:10.1001/jamaoto.2023.0160. , Corra
K, Watanabe
When attempting to compare with other vaccines and diseases, SARS-CoV-2 vaccine studies did not provide sufficient data for pooling. , Tahir
P, Ghidossi
Reuters, "COVID vaccine injury plaintiffs face long odds in U.S. compensation program," June 16, 2022 Federal Aviation Administration statements, April 27 and April 28, , Davidov
Affiliations, Neurological adverse events per 1,000,000 vaccine doses reported in VAERS stratified by COVID vaccine type. JA, Tamborska
World Health Organization. Of 306,907,697 COVID vaccine doses administered during the study timeframe, 314,610 (0.1%) people reported any adverse event and 105,214 (0.03%) reported neurological adverse events in a median of 1 day (IQR0-3) from inoculation. eCollection 2022. MS, Kim
[7] https://www.medpagetoday.com/infectiousdisease/covid19vaccine/93537 They found an increased risk of haemorrhagic stroke, a brain bleed, in the 28 days after vaccination with the BioNTech/Pfizer shot, at an estimated 60 extra cases per 10m people. These RCTs consisted of the final results of the phase 3 trials of the 4 major SARS-CoV-2 vaccines approved and widely administered worldwide (Pfizer/BioNTech, Moderna, Janssen, and Oxford/AstraZeneca). N,
Abstracts of Presentations at the Association of Clinical Scientists 143. V, Michos
JAMA Otolaryngol Head Neck Surg. and D.S.) et al. , Zhou
, Baden
Hanson KE, Goddard K, Lewis N, Fireman B, Myers TR, Bakshi N, Weintraub E, Donahue JG, Nelson JC, Xu S, Glanz JM, Williams JTB, Alpern JD, Klein NP. WHO coronavirus (COVID-19) dashboard. N, Shaygannejad
, Wan
A. A,
Albakri K, Khaity A, Atwan H, Saleh O, Al-Hajali M, Cadri S, Diab RA, Albazee E, Negida A.